Found 685 matching trials
Rivaroxaban Post-Transradial Access for the Prevention of Radial Artery Occlusion PHASE3 Coronary angiography is performed to evaluate for obstructive coronary arte...
Show More Learn More & Join Trial
A Study Using Electronic Health Information to Learn About Rivaroxaban Compared to Warfarin in Participants With Non-valvular Atrial Fibrillation (NVAF) and Diabetes N/A In people with type 2 diabetes, the body does not make enough of a hormone ...
Show More Location
US Optum De-Identified EHR data
Learn More & Join Trial
Rivaroxaban Versus Warfarin in Acute Ischemic Stroke With Atrial Fibrillation PHASE2 Rationale Acute ischemic stroke due to atrial fibrillation (AF) carries a h...
Show More Location
Asan Medical Center
Learn More & Join Trial
INVestIgation of rheumatiC AF Treatment Using Vitamin K Antagonists, Rivaroxaban or Aspirin Studies, Non-Inferiority PHASE3 This program is a comprehensive evaluation of rheumatic valvular heart dise...
Show More Location
Princess Marina Hospital
Learn More & Join Trial
Apixaban vs Rivaroxaban vs No Anticoagulant to Prevent EHIT After Great Saphenous Vein Laser Ablation PHASE4 Endothermal heat-induced thrombosis (EHIT) is a thrombotic complication spe...
Show More Location
Heart Artery and Vein Center of Fresno
Learn More & Join Trial
Prediction of the COBRRA VTE Anticoagulant Trial in Healthcare Claims Data N/A Investigators are building an empirical evidence base for real world data t...
Show More Location
Brigham and Women's Hospital
Learn More & Join Trial
Rivaroxaban With Diosmin in Long-term Treatment of Deep Vein Thrombosis PHASE4 The randomized clinical study aimed to assess the efficacy and safety of st...
Show More Location
Clinical Hospital no.1 of the President's Administration of Russian Federation
Learn More & Join Trial
Anticoagulation in Patients With Venous Thromboembolism and Cancer N/A This study is a retrospective analysis of observational cohorts using data ...
Show More Location
Pfizer Investigational Site
Learn More & Join Trial
Optimal Duration of Anticoagulation Therapy for Low-risk Pulmonary Embolism Patients With Cancer PHASE4 The primary purpose of this study is to determine the optimal duration of a...
Show More Location
Department of Cardiovascular Medicine, Kyoto University Graduate School of Medicine
Learn More & Join Trial
Anticoagulation With Rivaroxaban in Cardioversion -The ARC Study PHASE4 The purpose of this study is to determine that a new drug called "Rivaroxab...
Show More Location
Cook County Hospital
Learn More & Join Trial